Abano Healthcare Group Limited provided earnings guidance for the year 2016. For the year, the company expects gross revenue of range between $301 million to $305 million. Revenue expected in the range of $211 million to $215 million. EBITDA is expected to range between $25.2 million to $26.4 million. Underlying EBITDA is between $26.1 million to $27.3 million. NPAT is expected to range between $9.4 million to $10.2 million a year ago. Underlying NPAT is expected to range between $8.2 million to $9.0 million.